Study #2019-1002
A Randomized, Double Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1- Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD) Following Allogeneic Hema
MD Anderson Study Status
Not Accepting
Treatment Agent
Alpha-1 antitrypsin (AAT), Placebo
Description
Study CSL964_5001 will investigate the efficacy of AAT with corticosteroids compared with corticosteroids alone as first line therapy for patients with high-risk acute GVHD
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Graft Versus Host Disease (GVHD)
Study phase:
Phase III
Physician name:
Amin Alousi
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.